Progressive degeneration of dopaminergic neurons through TRP channel-induced cell death.

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMC 3996206)

Published in J Neurosci on April 23, 2014

Authors

Archana Nagarajan1, Ye Ning, Kaja Reisner, Zafir Buraei, Jan Petter Larsen, Oliver Hobert, Maria Doitsidou

Author Affiliations

1: Center for Organelle Research, University of Stavanger, 4036 Stavanger, Norway, Norwegian Center for Movement Disorders, Stavanger University Hospital, 4011 Stavanger, Norway, Department of Biology and Health Sciences, Pace University, New York, New York 10038, and Department of Biochemistry and Molecular Biophysics, Howard Hughes Medical Institute, Columbia University Medical Center, New York, New York 10032.

Articles cited by this

The genetics of Caenorhabditis elegans. Genetics (1974) 102.14

NIH Image to ImageJ: 25 years of image analysis. Nat Methods (2012) 84.41

TRP channels. Annu Rev Biochem (2007) 8.09

Genome-wide RNAi screening in Caenorhabditis elegans. Methods (2003) 7.83

C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway. Neuron (2000) 6.00

TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet (2005) 5.53

Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol (2004) 5.31

The mec-4 gene is a member of a family of Caenorhabditis elegans genes that can mutate to induce neuronal degeneration. Nature (1991) 5.30

'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature (2007) 5.03

A Drosophila mechanosensory transduction channel. Science (2000) 4.81

Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. Dev Cell (2010) 3.72

Rapid single nucleotide polymorphism mapping in C. elegans. BMC Genomics (2005) 3.57

Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet (2009) 3.56

A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. Neuron (2010) 3.31

A C. elegans stretch receptor neuron revealed by a mechanosensitive TRP channel homologue. Nature (2006) 3.20

PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol Cell (2009) 3.17

Somatic misexpression of germline P granules and enhanced RNA interference in retinoblastoma pathway mutants. Nature (2005) 2.98

C. elegans TRP family protein TRP-4 is a pore-forming subunit of a native mechanotransduction channel. Neuron (2010) 2.89

Analysis of osm-6, a gene that affects sensory cilium structure and sensory neuron function in Caenorhabditis elegans. Genetics (1998) 2.83

A transmembrane domain of the putative channel subunit MEC-4 influences mechanotransduction and neurodegeneration in C. elegans. Nature (1994) 2.17

Techniques for analysis, sorting, and dispensing of C. elegans on the COPAS flow-sorting system. Methods Mol Biol (2006) 2.12

Gene regulatory logic of dopamine neuron differentiation. Nature (2009) 2.04

Calcium signaling and neurodegenerative diseases. Trends Mol Med (2009) 2.03

mRNA distribution analysis of human TRPC family in CNS and peripheral tissues. Brain Res Mol Brain Res (2002) 1.98

A helix-breaking mutation in TRPML3 leads to constitutive activity underlying deafness in the varitint-waddler mouse. Proc Natl Acad Sci U S A (2007) 1.91

Necrotic cell death in C. elegans requires the function of calreticulin and regulators of Ca(2+) release from the endoplasmic reticulum. Neuron (2001) 1.90

MAQGene: software to facilitate C. elegans mutant genome sequence analysis. Nat Methods (2009) 1.84

A point mutation in TRPC3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice. Proc Natl Acad Sci U S A (2009) 1.66

Dantrolene inhibition of ryanodine receptor Ca2+ release channels. Molecular mechanism and isoform selectivity. J Biol Chem (2001) 1.63

Automated screening for mutants affecting dopaminergic-neuron specification in C. elegans. Nat Methods (2008) 1.61

The role of transient receptor potential cation channels in Ca2+ signaling. Cold Spring Harb Perspect Biol (2010) 1.56

Gain-of-function mutation in TRPML3 causes the mouse Varitint-Waddler phenotype. J Biol Chem (2007) 1.56

TRPV4 mutations and cytotoxic hypercalcemia in axonal Charcot-Marie-Tooth neuropathies. Neurology (2011) 1.56

The neural circuits and sensory channels mediating harsh touch sensation in Caenorhabditis elegans. Nat Commun (2011) 1.45

Evidence for calcium-reducing and excito-protective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons. Neuron (1991) 1.45

Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium (2010) 1.43

Transient receptor potential channelopathies. Pflugers Arch (2010) 1.40

A TRPM7 variant shows altered sensitivity to magnesium that may contribute to the pathogenesis of two Guamanian neurodegenerative disorders. Proc Natl Acad Sci U S A (2005) 1.37

Novel mechanism of massive photoreceptor degeneration caused by mutations in the trp gene of Drosophila. J Neurosci (2000) 1.35

The neurotoxic MEC-4(d) DEG/ENaC sodium channel conducts calcium: implications for necrosis initiation. Nat Neurosci (2004) 1.34

Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease. Cell Calcium (2010) 1.34

Calcium dysregulation in Alzheimer's disease. Neurochem Int (2007) 1.30

Neuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington's disease treatment. Chem Biol (2011) 1.25

Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling. J Cell Mol Med (2008) 1.24

Involvement of transient receptor potential-like channels in responses to mGluR-I activation in midbrain dopamine neurons. Eur J Neurosci (2003) 1.19

Yeast screens show aromatic residues at the end of the sixth helix anchor transient receptor potential channel gate. Proc Natl Acad Sci U S A (2007) 1.15

Sensory regulation of C. elegans male mate-searching behavior. Curr Biol (2008) 1.13

Towards unveiling the genetics of neurodegenerative diseases. Semin Neurol (2012) 1.12

Yeast gain-of-function mutations reveal structure-function relationships conserved among different subfamilies of transient receptor potential channels. Proc Natl Acad Sci U S A (2007) 1.09

Animal models of Parkinson's disease: vertebrate genetics. Cold Spring Harb Perspect Med (2012) 1.08

Neuronal calcium signaling: function and dysfunction. Cell Mol Life Sci (2014) 1.07

TRPC1 inhibits apoptotic cell degeneration induced by dopaminergic neurotoxin MPTP/MPP(+). Cell Calcium (2009) 1.07

Temperature sensitivity of dopaminergic neurons of the substantia nigra pars compacta: involvement of transient receptor potential channels. J Neurophysiol (2005) 1.03

C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease. Dev Dyn (2010) 0.99

TRPC channels and their implication in neurological diseases. CNS Neurol Disord Drug Targets (2010) 0.97

A combinatorial regulatory signature controls terminal differentiation of the dopaminergic nervous system in C. elegans. Genes Dev (2013) 0.97

Huntington's disease, calcium, and mitochondria. Biofactors (2011) 0.96

A dominant mutation in a neuronal acetylcholine receptor subunit leads to motor neuron degeneration in Caenorhabditis elegans. J Neurosci (2010) 0.94

TRPs in the Brain. Rev Physiol Biochem Pharmacol (2012) 0.92

Calcium homeostasis in aging neurons. Front Genet (2012) 0.86

Evidence that TRPC1 is involved in hippocampal glutamate-induced cell death. Neurosci Lett (2008) 0.85

Mutation of a TADR protein leads to rhodopsin and Gq-dependent retinal degeneration in Drosophila. J Neurosci (2008) 0.79

Articles by these authors

A microRNA controlling left/right neuronal asymmetry in Caenorhabditis elegans. Nature (2003) 12.93

Perfect seed pairing is not a generally reliable predictor for miRNA-target interactions. Nat Struct Mol Biol (2006) 7.97

Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat Immunol (2002) 5.67

MicroRNAs act sequentially and asymmetrically to control chemosensory laterality in the nematode. Nature (2004) 5.31

Caenorhabditis elegans mutant allele identification by whole-genome sequencing. Nat Methods (2008) 4.71

MicroRNAs acting in a double-negative feedback loop to control a neuronal cell fate decision. Proc Natl Acad Sci U S A (2005) 3.69

Genome sequencing and comparative analysis of Saccharomyces cerevisiae strain YJM789. Proc Natl Acad Sci U S A (2007) 3.52

Direct conversion of C. elegans germ cells into specific neuron types. Science (2010) 3.31

Molecular architecture of a miRNA-regulated 3' UTR. RNA (2008) 3.11

Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord (2006) 2.96

A transcriptional regulatory cascade that controls left/right asymmetry in chemosensory neurons of C. elegans. Genes Dev (2003) 2.70

Genetic screens for Caenorhabditis elegans mutants defective in left/right asymmetric neuronal fate specification. Genetics (2007) 2.48

Genomic cis-regulatory architecture and trans-acting regulators of a single interneuron-specific gene battery in C. elegans. Dev Cell (2004) 2.47

Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord (2006) 2.47

Functional mapping of neurons that control locomotory behavior in Caenorhabditis elegans. J Neurobiol (2003) 2.37

The molecular diversity of glycosaminoglycans shapes animal development. Annu Rev Cell Dev Biol (2006) 2.36

The molecular signature and cis-regulatory architecture of a C. elegans gustatory neuron. Genes Dev (2007) 2.34

Comparing platforms for C. elegans mutant identification using high-throughput whole-genome sequencing. PLoS One (2008) 2.24

A C. elegans CLIC-like protein required for intracellular tube formation and maintenance. Science (2003) 2.19

Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. JAMA Neurol (2013) 2.19

A toolkit and robust pipeline for the generation of fosmid-based reporter genes in C. elegans. PLoS One (2009) 2.18

Immunoglobulin-domain proteins required for maintenance of ventral nerve cord organization. Science (2002) 2.14

Endovascular acute stroke treatment performed by vascular interventional radiologists: is it safe and efficacious? Cardiovasc Intervent Radiol (2012) 2.06

Gene regulatory logic of dopamine neuron differentiation. Nature (2009) 2.04

C. elegans mutant identification with a one-step whole-genome-sequencing and SNP mapping strategy. PLoS One (2010) 2.02

LIM homeobox gene-dependent expression of biogenic amine receptors in restricted regions of the C. elegans nervous system. Dev Biol (2003) 1.98

Transgenerational inheritance of an acquired small RNA-based antiviral response in C. elegans. Cell (2011) 1.96

Oxygen levels affect axon guidance and neuronal migration in Caenorhabditis elegans. Nat Neurosci (2008) 1.92

Early embryonic programming of neuronal left/right asymmetry in C. elegans. Curr Biol (2006) 1.92

MAQGene: software to facilitate C. elegans mutant genome sequence analysis. Nat Methods (2009) 1.84

Structural and molecular basis of the assembly of the TRPP2/PKD1 complex. Proc Natl Acad Sci U S A (2009) 1.84

Analysis of multiple ethyl methanesulfonate-mutagenized Caenorhabditis elegans strains by whole-genome sequencing. Genetics (2010) 1.76

Differential sulfations and epimerization define heparan sulfate specificity in nervous system development. Neuron (2004) 1.75

Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease. Parkinsonism Relat Disord (2013) 1.74

A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol (2010) 1.70

A conserved postsynaptic transmembrane protein affecting neuromuscular signaling in Caenorhabditis elegans. J Neurosci (2004) 1.70

Searching for neuronal left/right asymmetry: genomewide analysis of nematode receptor-type guanylyl cyclases. Genetics (2006) 1.68

Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease. J Neurol Neurosurg Psychiatry (2012) 1.66

CloudMap: a cloud-based pipeline for analysis of mutant genome sequences. Genetics (2012) 1.64

Dissecting the genetic basis of resistance to malaria parasites in Anopheles gambiae. Science (2009) 1.63

Automated screening for mutants affecting dopaminergic-neuron specification in C. elegans. Nat Methods (2008) 1.61

Two distinct types of neuronal asymmetries are controlled by the Caenorhabditis elegans zinc finger transcription factor die-1. Genes Dev (2013) 1.58

Embryonic priming of a miRNA locus predetermines postmitotic neuronal left/right asymmetry in C. elegans. Cell (2012) 1.58

New insights into the diversity and function of neuronal immunoglobulin superfamily molecules. Annu Rev Neurosci (2003) 1.58

CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry (2010) 1.55

Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study. J Neurol Neurosurg Psychiatry (2009) 1.54

Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology (2005) 1.53

High-resolution transcription atlas of the mitotic cell cycle in budding yeast. Genome Biol (2010) 1.51

Increased risk of sudden unexpected death in epilepsy in females using lamotrigine: a nested, case-control study. Epilepsia (2011) 1.50

Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease. Parkinsonism Relat Disord (2007) 1.48

The rate of cognitive decline in Parkinson disease. Arch Neurol (2004) 1.44

Epidemiology of Parkinson's disease. J Neurol (2008) 1.38

Linking asymmetric cell division to the terminal differentiation program of postmitotic neurons in C. elegans. Dev Cell (2009) 1.35

Reporter gene fusions. WormBook (2006) 1.34

Predictors and course of health-related quality of life in Parkinson's disease. Mov Disord (2008) 1.33

Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease. Neurobiol Aging (2012) 1.31

Heparan sulfate proteoglycan-dependent induction of axon branching and axon misrouting by the Kallmann syndrome gene kal-1. Proc Natl Acad Sci U S A (2002) 1.31

Differential functions of the C. elegans FGF receptor in axon outgrowth and maintenance of axon position. Neuron (2004) 1.31

CisOrtho: a program pipeline for genome-wide identification of transcription factor target genes using phylogenetic footprinting. BMC Bioinformatics (2004) 1.30

Hypoxia activates a latent circuit for processing gustatory information in C. elegans. Nat Neurosci (2010) 1.29

Caenorhabditis elegans ABL-1 antagonizes p53-mediated germline apoptosis after ionizing irradiation. Nat Genet (2004) 1.29

Lateralized gustatory behavior of C. elegans is controlled by specific receptor-type guanylyl cyclases. Curr Biol (2009) 1.27

Two neuronal, nuclear-localized RNA binding proteins involved in synaptic transmission. Curr Biol (2003) 1.26

Coordinated regulation of cholinergic motor neuron traits through a conserved terminal selector gene. Nat Neurosci (2011) 1.26

An unusual Zn-finger/FH2 domain protein controls a left/right asymmetric neuronal fate decision in C. elegans. Development (2006) 1.26

Verbal memory in drug-naive, newly diagnosed Parkinson's disease. The retrieval deficit hypothesis revisited. Neuropsychology (2011) 1.22

Modular control of glutamatergic neuronal identity in C. elegans by distinct homeodomain proteins. Cell (2013) 1.20

Cis-regulatory mechanisms of left/right asymmetric neuron-subtype specification in C. elegans. Development (2009) 1.20

Cognitive predictors of dementia in Parkinson's disease: a community-based, 4-year longitudinal study. J Geriatr Psychiatry Neurol (2005) 1.19

Germ cell migration in zebrafish is dependent on HMGCoA reductase activity and prenylation. Dev Cell (2004) 1.18

The Groucho ortholog UNC-37 interacts with the short Groucho-like protein LSY-22 to control developmental decisions in C. elegans. Development (2010) 1.18

Chloride intracellular channel 4 is involved in endothelial proliferation and morphogenesis in vitro. Angiogenesis (2009) 1.17

Mosaic genome architecture of the Anopheles gambiae species complex. PLoS One (2007) 1.12

Extracellular sugar modifications provide instructive and cell-specific information for axon-guidance choices. Curr Biol (2008) 1.12

A novel C. elegans zinc finger transcription factor, lsy-2, required for the cell type-specific expression of the lsy-6 microRNA. Development (2005) 1.10

Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study. Parkinsonism Relat Disord (2008) 1.08

Depressive symptom profile in Parkinson's disease: a comparison with depression in elderly patients without Parkinson's disease. Int J Geriatr Psychiatry (2006) 1.08

Functional dissection of the C. elegans cell adhesion molecule SAX-7, a homologue of human L1. Mol Cell Neurosci (2007) 1.08

An interneuronal chemoreceptor required for olfactory imprinting in C. elegans. Science (2005) 1.08

Removal of Polycomb repressive complex 2 makes C. elegans germ cells susceptible to direct conversion into specific somatic cell types. Cell Rep (2012) 1.07

Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation. Neurobiol Dis (2006) 1.06

Cognitive profiles of individual patients with Parkinson's disease and dementia: comparison with dementia with lewy bodies and Alzheimer's disease. Mov Disord (2006) 1.06

Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment. Mov Disord (2005) 1.05

Vector-free DNA constructs improve transgene expression in C. elegans. Nat Methods (2008) 1.05

Cis-regulatory mutations in the Caenorhabditis elegans homeobox gene locus cog-1 affect neuronal development. Genetics (2009) 1.05

The Arabidopsis DJ-1a protein confers stress protection through cytosolic SOD activation. J Cell Sci (2010) 1.05

DIG-1, a novel giant protein, non-autonomously mediates maintenance of nervous system architecture. Development (2006) 1.03

Direct inhibition of P/Q-type voltage-gated Ca2+ channels by Gem does not require a direct Gem/Cavbeta interaction. Proc Natl Acad Sci U S A (2010) 1.03

Lineage programming: navigating through transient regulatory states via binary decisions. Curr Opin Genet Dev (2010) 1.01

Neuron-type specific regulation of a 3'UTR through redundant and combinatorially acting cis-regulatory elements. RNA (2009) 1.00

A Genome-Wide RNAi Screen for Factors Involved in Neuronal Specification in Caenorhabditis elegans. PLoS Genet (2011) 0.99

Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: frequent but mild. Mov Disord (2010) 0.99

Looking beyond development: maintaining nervous system architecture. Curr Top Dev Biol (2009) 0.98

A novel Eph receptor-interacting IgSF protein provides C. elegans motoneurons with midline guidepost function. Curr Biol (2006) 0.98

The C. elegans Tailless/TLX transcription factor nhr-67 controls neuronal identity and left/right asymmetric fate diversification. Development (2009) 0.98

Identification of spatial and temporal cues that regulate postembryonic expression of axon maintenance factors in the C. elegans ventral nerve cord. Development (2003) 0.97

APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study. J Geriatr Psychiatry Neurol (2009) 0.97

A combinatorial regulatory signature controls terminal differentiation of the dopaminergic nervous system in C. elegans. Genes Dev (2013) 0.97